We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

World’s First and Only Portable PET Scanner Awarded FDA Clearance

By MedImaging International staff writers
Posted on 20 Aug 2021
Print article
Image: BBX-PET scanner (Photo courtesy of Prescient Imaging LLC)
Image: BBX-PET scanner (Photo courtesy of Prescient Imaging LLC)
The world’s first and only portable positron emission tomography (PET) scanner has been granted 510k FDA clearance.

The portable PET scanner named BBX-PET from Prescient Imaging LLC (Hawthorne, CA, USA) is the first and only portable PET scanner that is cleared for use by the US Federal Food and Drug Administration. The BBX is a portable PET scanner for imaging of breast, brain, and extremities. Its gantry can move up to allow brain imaging while the patient is seated. It can also move down to image the breast without compression, while a patient is lying on a biopsy table or rotate and allow imaging the breast, hand, or leg in a seated position.

The most important feature of BBX-PET scanners is that they are portable and can be wheeled to the point-of-care in a physician’s office, a hospital room, ER, OR, or nursing homes. Because the organ-specific scanner is approximately 300 lb, it can easily be transported to deliver point-of-care molecular imaging. The logistical advantage of BBX-PET will greatly expand the availability of this vital imaging modality.

“BBX-PET scanner is intended to obtain positron emission tomography (PET) images of parts of the human body that fit in the patient aperture (e.g., head) to detect abnormal patterns of distribution of radioactivity after injection of a positron-emitting radiopharmaceutical. This information can assist in research, diagnosis, therapeutic planning, and therapeutic outcome assessment,” said Dr. Farhad Daghighian, CEO and co-founder of Prescient Imaging LLC. “We expect our scanners provide unparalleled opportunities for growth in neurology, geriatric psychiatry, and radiation oncology centers. In addition, BBX-PET scanners provide higher resolution than conventional PET scanners and at a lower cost.”

“PET imaging of the brain is essential to the accurate diagnosis of Alzheimer’s disease”, according to Michael Rafii MD, Ph.D., Associate Professor of Neurology at the Keck School of Medicine of the University of Southern California. “As new therapeutics become available for the treatment of Alzheimer’s Disease, accurate diagnosis will be critical before initiation of any disease-modifying therapy.”

Related Links:
Prescient Imaging LLC


Print article
CIRS
Radcal

Channels

Industry News

view channel
Illustration

Fujifilm Introduces AI-Powered Chest X-Ray Software in Collaboration with Lunit

Fujifilm Corporation (Tokyo, Japan) has announced that its software for analyzing chest X-ray developed with the core artificial intelligence (AI) technology of Lunit (Seoul, Korea) will be commercially... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.